4Liu CM, Sheen TS, Ko JY, et al. Circulating intercellular adhesion molecule 1 ( ICAM-1 ) , E-selectin and vascular cell adhesion molecule 1 (VCAM-1) in head and neck cancer [J]. Br J Cancer,1999,79(2):360-362.
5Ruco LP, Stoppacciaro A, Uccini S, et al. Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in undifferentiated nasopharyngeal carcinoma (lymphoepithelioma) and in malignant epithelial tumors [J]. Hum Pathol, 1994,25(9) :924.
6Ho JW, Poon RT, Tong CS, et al. Clinical significance of sermn vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma [ J]. World J Gastroenterol, 2004,10(14) :2014-8.
7Bourges D, Chevaleyre C, Wang C, et al. Differential expression of adhesion molecules and chemokines between nasal and small intestinal mucosae : implications for T- and sIgA ( + ) B-lymphocyte recruitment [J]. Immunology, 2007,106(1) :16.
8Kupczyk M, Kupry I, Danilewicz M, et al. Adhesion molecules and their ligands in nasal polyps of spirin-hypersensitive patients [ J]. Ann Allergy Asthma Immunol, 2006, 96(1) :105-11.
9O' Hanlon DM, Fitzsimons H, Lynch J, et al. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1 ) in breast carcinoma [ J]. Eur J Cancer,2002,38 (17) :2252- 7.
10Perabo F, Sharma S, Gierer R, et al. Circulating intercellular adhesion molecule-1 ( ICAM-1 ), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies [J]. Indian J Cancer,2001,38(1) :1-7.
